HRT and osteoporosis

Adami, 1989, Transdermal estradiol in the treatment of post-menopausal bone loss, Bone and Mineral, 7, 79, 10.1016/0169-6009(89)90064-0 Anderson, 1978, Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol, British Medical Journal, 1, 140, 10.1136/bmj.1.6106.140 Barlow, 1990, Hormone replacement therapy, 135 Barlow, 1992, Hormone replacement therapy and other menopause associated conditions, British Medical Bulletin, 48, 356, 10.1093/oxfordjournals.bmb.a072551 Barlow, 1986, Long-term hormone implant therapy—hormonal and clinical effects, Obstetrics and Gynecology, 67, 321 Barlow, 1989, A study of the experience of Glasgow women in the climacteric years, British Journal of Obstetrics and Gynaecology, 96, 1192, 10.1111/j.1471-0528.1989.tb03195.x Barlow, 1991, Study of general practice consultations and menopausal problems, British Medical Journal, 302, 274, 10.1136/bmj.302.6771.274 Barrett-Connor, 1989, Estrogen replacement and coronary heart disease, Cardiovascular Clinics, 19, 159 Bergkvist, 1989, The risk of breast cancer after estrogen and estrogen-progestin replacement, New England Journal of Medicine, 321, 293, 10.1056/NEJM198908033210505 Bhatia, 1989, Effects of estrogen on urethral function in women with urinary incontinence, American Journal of Obstetrics and Gynecology, 160, 176, 10.1016/0002-9378(89)90114-2 Bungay, 1980, Study of symptoms in middle-life with special reference to the menopause, British Medical Journal, 281, 181, 10.1136/bmj.281.6234.181 Christensen, 1982, Dose-response evaluation of cyclic estrogen-gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions, American Journal of Obstetrics and Gynecology, 144, 873, 10.1016/0002-9378(82)90176-4 Christiansen, 1980, Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females, European Journal of Clinical Investigation, 10, 273, 10.1111/j.1365-2362.1980.tb00033.x Christiansen, 1981, Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy, Lancet, ii, 459, 10.1016/S0140-6736(81)91848-1 Coope, 1975, Effects of ‘natural oestrogen’ replacement therapy on menopausal symptoms and blood clotting, British Medical Journal, 4, 139, 10.1136/bmj.4.5989.139 Criqui, 1988, Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community, American Journal of Epidemiology, 128, 606, 10.1093/oxfordjournals.aje.a115008 Daly, 1992, HRT: an analysis of benefits, risks and costs, British Medical Bulletin, 48, 368, 10.1093/oxfordjournals.bmb.a072552 Devor, 1992, Estrogen replacement therapy and the risk of venous thrombosis, American Journal of Medicine, 92, 275, 10.1016/0002-9343(92)90077-O Dow, 1983, Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study, British Journal of Obstetrics and Gynaecology, 90, 361, 10.1111/j.1471-0528.1983.tb08924.x Dupont, 1991, Menopausal estrogen replacement therapy and breast cancer, Archives of Internal Medicine, 151, 67, 10.1001/archinte.1991.00400010089011 Ettinger, 1985, Long-term estrogen replacement therapy prevents bone loss and fractures, Annals of Internal Medicine, 102, 319, 10.7326/0003-4819-102-3-319 Ettinger, 1987, Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium, Annals of Internal Medicine, 106, 40, 10.7326/0003-4819-106-1-40 Fletcher, 1988, Effects of conjugated equine oestrogens with and without the addition of cyclical norgestrel on serum and urine electrolytes, and the biochemical indices of bone metabolism and liver function, Maturitas, 9, 347, 10.1016/0378-5122(88)90100-4 Fletcher, 1991, Short-term changes in lipoproteins and apoproteins during cyclical oestrogen-progestogen replacement therapy, Maturitas, 14, 33, 10.1016/0378-5122(91)90145-G Gangar, 1991, Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause, Lancet, 338, 839, 10.1016/0140-6736(91)91500-T Gath, 1990, Psychological effects of the menopause, 35 Godsland, 1987, Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions, American Heart Journal, 114, 1467, 10.1016/0002-8703(87)90552-7 Gordon, 1978, Menopause and coronary heart disease. The Framingham Study, Archives of Internal Medicine, 89, 157 Grodin, 1973, Source of estrogen production in postmenopausal women, Journal of Clinical Endocrinology and Metabolism, 36, 207, 10.1210/jcem-36-2-207 Henderson, 1988, Estrogen replacement therapy and protection from acute myocardial infarction [published erratum appears in American Journal of Obstetrics and Gynecology (1988) 159(6): 1574], American Journal of Obstetrics and Gynecology, 159, 312, 10.1016/S0002-9378(88)80074-7 Henderson, 1991, Decreased mortality in users of estrogen replacement therapy, Archives of Internal Medicine, 151, 75, 10.1001/archinte.1991.00400010095012 Hirvonen, 1981, Effects of different progestogens on lipoproteins during postmenopausal replacement therapy, New England Journal of Medicine, 304, 560, 10.1056/NEJM198103053041002 Horsman, 1977, Prospective trial of oestrogen and calcium in postmenopausal women, British Medical Journal, 2, 789, 10.1136/bmj.2.6090.789 Hunt, 1987, Long term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy, British Journal of Obstetrics and Gynaecology, 94, 620, 10.1111/j.1471-0528.1987.tb03166.x Hutchinson, 1979, Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study, Lancet, ii, 705, 10.1016/S0140-6736(79)90640-8 Iosif, 1984, Prevalence of genito-urinary symptoms in the late menopause, Acta Obstetrica et Gynecologica Scandinavica, 63, 257, 10.3109/00016348409155509 Jacobs, 1981, Hormonal changes after the menopause and during hormone replacement therapy, 235 Kalache, 1991, Risk factors for breast cancer, Clinical Oncology, 1, 661 Kanis, 1990, Osteoporosis: causes and therapeutic implications, 45 Kreiger, 1982, A epidemiologic study of hip fracture in postmenopausal women, American Journal of Epidemiology, 116, 141, 10.1093/oxfordjournals.aje.a113388 Lindsay, 1990, Estrogen treatment of patients with established postmenopausal osteoporosis, Obstetrics and Gynecology, 76, 290 Lindsay, 1976, Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment, Lancet, ii, 1038, 10.1016/S0140-6736(76)92217-0 Lindsay, 1978, Bone response to termination of oestrogen treatment, Lancet, i, 1325, 10.1016/S0140-6736(78)92402-9 Lindsay, 1984, The minimum effective dose of estrogen for prevention of postmenopausal bone loss, Obstetrics and Gynecology, 63, 759 Lindsay, 1987, Inter-relationship of bone loss and its prevention, and fracture expression, 508 Lobo, 1991, Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women, Journal of Clinical Endocrinology and Metabolism, 73, 925, 10.1210/jcem-73-5-925 Lobo, 1992, Estrogen and the risk of coagulation, American Journal of Medicine, 92, 283, 10.1016/0002-9343(92)90078-P MacDonald, 1974, The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia, Gynecologic Oncology, 2, 259, 10.1016/0090-8258(74)90015-8 MacDonald, 1978, Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer, American Journal of Obstetrics and Gynecology, 130, 448, 10.1016/0002-9378(78)90287-9 McKinlay, 1972, An investigation of the age at menopause, Journal of Biosocial Science, 4, 161, 10.1017/S0021932000008464 McKinlay, 1974, The menopausal syndrome, British Journal of Preventive and Social Medicine, 28, 108 Mack, 1976, Estrogens and endometrial cancer in a retirement community, New England Journal of Medicine, 294, 1262, 10.1056/NEJM197606032942304 Magos, 1985, Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women, Obstetrics and Gynecology, 65, 496 Matta, 1988, Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women, Clinical Endocrinology (Oxford), 29, 45, 10.1111/j.1365-2265.1988.tb00248.x Meema, 1975, Preventive effect of estrogen on postmenopausal bone loss, Archives of Internal Medicine, 135, 1436, 10.1001/archinte.1975.00330110026004 Naessen, 1990, Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study, Annals of Internal Medicine, 113, 95, 10.7326/0003-4819-113-2-95 Padwick, 1986, A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens, New England Journal of Medicine, 315, 930, 10.1056/NEJM198610093151504 Paganini-Hill, 1981, Menopausal estrogen therapy and hip fractures, Annals of Internal Medicine, 95, 28, 10.7326/0003-4819-95-1-28 Paganini-Hill, 1988, Postmenopausal oestrogen treatment and stroke: a prospective study, British Medical Journal, 297, 519, 10.1136/bmj.297.6647.519 Paganini-Hill, 1989, Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study, British Journal of Cancer, 59, 445, 10.1038/bjc.1989.91 Parris, 1967, Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis, American Journal of Obstetrics and Gynecology, 99, 155, 10.1016/0002-9378(67)90314-6 Persson, 1989, Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study, British Medical Journal, 298, 147, 10.1136/bmj.298.6667.147 Pines, 1992, Menopause-induced changes in Doppler-derived parameters of aortic flow in healthy women, American Journal of Cardiology, 69, 1104, 10.1016/0002-9149(92)90877-2 Quigley, 1987, Estrogen therapy arrests bone loss in elderly women, American Journal of Obstetrics and Gynecology, 156, 1516, 10.1016/0002-9378(87)90025-1 Ralston, 1984, Effect of subdermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy, Maturitas, 6, 341, 10.1016/0378-5122(84)90006-9 Ravnikar, 1987, Compliance with hormone therapy, American Journal of Obstetrics and Gynecology, 156, 1332, 10.1016/0002-9378(87)90173-6 Rees, 1991, Quantitation of hormone replacement induced withdrawal bleeds, British Journal of Obstetrics and Gynaecology, 98, 106, 10.1111/j.1471-0528.1991.tb10322.x Ross, 1989, Stroke prevention and oestrogen replacement therapy, Lancet, i, 505, 10.1016/S0140-6736(89)91411-6 Sarrel, 1990, Ovarian hormones and the circulation, Maturitas, 12, 287, 10.1016/0378-5122(90)90008-T Semmens, 1982, Estrogen deprivation and vaginal function in postmenopausal women, Journal of the American Medical Association, 248, 445, 10.1001/jama.1982.03330040033027 Smith, 1975, Association of exogenous estrogen and endometrial carcinoma, New England Journal of Medicine, 293, 1164, 10.1056/NEJM197512042932302 Stampfer, 1991, Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence, Preventive Medicine, 20, 47, 10.1016/0091-7435(91)90006-P Stampfer, 1990, Menopause and heart disease. A review, Annals of the New York Academy of Sciences, 592, 193, 10.1111/j.1749-6632.1990.tb30329.x Stampfer, 1991, Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study, New England Journal of Medicine, 325, 756, 10.1056/NEJM199109123251102 Steinberg, 1991, A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer, Journal of the American Medical Association, 265, 1985, 10.1001/jama.1991.03460150089030 Sullivan, 1990, Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women, Archives of Internal Medicine, 150, 2557, 10.1001/archinte.1990.00390230101014 Thompson, 1973, Menopausal age and symptomatology in a general practice, Journal of Biosocial Science, 5, 71, 10.1017/S0021932000008956 Tikkanen, 1981, Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment, Clinica Chimica Acta, 115, 63, 10.1016/0009-8981(81)90107-8 Versi, 1988, Correlation of urethral physiology and skin collagen in postmenopausal women, British Journal of Obstetrics and Gynaecology, 95, 147, 10.1111/j.1471-0528.1988.tb06844.x Weiss, 1980, Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen, New England Journal of Medicine, 303, 1195, 10.1056/NEJM198011203032102 Whitehead, 1987, Controversies concerning the safety of estrogen replacement therapy, American Journal of Obstetrics and Gynecology, 156, 1313, 10.1016/0002-9378(87)90170-0 Wren, 1983, The effect of type and dose of oestrogen on the blood pressure of post-menopausal women, Maturitas, 5, 135, 10.1016/0378-5122(83)90009-9 Ylikorkala, 1984, Vasoconstrictory thromboxane A2 and vasodilatory prostacyclin in climacteric women: effect of oestrogen-progestogen therapy, Maturitas, 5, 201, 10.1016/0378-5122(84)90053-7 Ziel, 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, New England Journal of Medicine, 293, 1167, 10.1056/NEJM197512042932303